Muhammad Rakib Al-Mamun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Muhammad Rakib Al-Mamun has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Md. Saiful Islam
Pharmaceutical Sciences Research Division, BCSIR Dhaka Laboratories Bangladesh Council of Scientific and Industrial Research (BCSIR) Dhaka Bangladesh
1 shared publication - Mohiminul Adib
Department of Pharmaceutical Chemistry , Faculty of Pharmacy , University of Dhaka , Dhaka 1000 , Bangladesh , du.ac.bd
1 shared publication - Monira Ahsan
Department of Pharmaceutical Chemistry , Faculty of Pharmacy , University of Dhaka , Dhaka 1000 , Bangladesh , du.ac.bd
1 shared publication - Sania Ashrafi
Department of Pharmaceutical Chemistry , Faculty of Pharmacy , University of Dhaka , Dhaka , Bangladesh , du.ac.bd
1 shared publication - Zubaer Ahmed
Department of Pharmaceutical Chemistry , Faculty of Pharmacy , University of Dhaka , Dhaka 1000 , Bangladesh , du.ac.bd
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Food Biochemistry
- Vol. 2026 (1) , 4312846
Analgesic, Anti‐Inflammatory, Antipyretic, and Antioxidant Activity of Lophopetalum wightianum Leaf Extract: A Phytochemical and Biological Study
Lophopetalum wightianum Arn. has previously been identified as a medicinal plant reported to contain promising anti‐inflammatory and anticancer compounds, including lupeol and pristimerin. Compared to other species of the Lophopetalum genus, L. wightianum remains largely unstudied, and this study aimed to assess the analgesic, anti‐inflammatory, antipyretic, and antioxidant potential of the methanolic extract of its leaves and undertake a phytochemical investigation. Gas chromatography–mass spectrometry (GC–MS) analysis of the crude extracts indicated the presence of steroids, triterpenoids, and fatty acid esters. Lupeol, a triterpenoid, was isolated from the hexane fraction of the bark. In the writhing test of analgesic potential, 400 and 500 mg/kg dose groups of the leaf extract showed reduced mean writhing counts of 35.60 ± 0.87 ( p < 0.01) and 27.20 ± 1.59 ( p < 0.001), respectively, compared to the control group (42.20 ± 1.16). At the 500 mg/kg dose, the extract reduced licking duration by 40.09 ± 0.02% in phase one and 44.66 ± 0.01% in phase two of the licking test. Significant protection level (38.21 ± 1.56%, p < 0.001) was observed in the hotplate test at a dose of 500 mg/kg at 0.5 h, which was close to diclofenac sodium (40.70 ± 1.10%). A dose‐dependent effect was evident in the writhing, licking, and hotplate tests. In the anti‐inflammatory test, the highest anti‐inflammatory effect (36.79 ± 0.01%) was observed at 3 h at the highest dose, and a dose‐dependent effect was apparent. Finally, in the antipyretic activity test, the crude extract was most effective at a dose of 500 mg/kg. Overall, the findings indicate the presence of potential therapeutic bioactive compounds in the plant.
- 1 January 2026
- Published by Wiley in Journal of Food Biochemistry
- Vol. 2026 (1) , 4312846
Open AccessAnalgesic, Anti‐Inflammatory, Antipyretic, and Antioxidant Activity of Lophopetalum wightianum Leaf Extract: A Phytochemical and Biological Study
Lophopetalum wightianum Arn. has previously been identified as a medicinal plant reported to contain promising anti‐inflammatory and anticancer compounds, including lupeol and pristimerin. Compared to other species of the Lophopetalum genus, L. wightianum remains largely unstudied, and this study aimed to assess the analgesic, anti‐inflammatory, antipyretic, and antioxidant potential of the methanolic extract of its leaves and undertake a phytochemical investigation. Gas chromatography–mass spectrometry (GC–MS) analysis of the crude extracts indicated the presence of steroids, triterpenoids, and fatty acid esters. Lupeol, a triterpenoid, was isolated from the hexane fraction of the bark. In the writhing test of analgesic potential, 400 and 500 mg/kg dose groups of the leaf extract showed reduced mean writhing counts of 35.60 ± 0.87 ( p < 0.01) and 27.20 ± 1.59 ( p < 0.001), respectively, compared to the control group (42.20 ± 1.16). At the 500 mg/kg dose, the extract reduced licking duration by 40.09 ± 0.02% in phase one and 44.66 ± 0.01% in phase two of the licking test. Significant protection level (38.21 ± 1.56%, p < 0.001) was observed in the hotplate test at a dose of 500 mg/kg at 0.5 h, which was close to diclofenac sodium (40.70 ± 1.10%). A dose‐dependent effect was evident in the writhing, licking, and hotplate tests. In the anti‐inflammatory test, the highest anti‐inflammatory effect (36.79 ± 0.01%) was observed at 3 h at the highest dose, and a dose‐dependent effect was apparent. Finally, in the antipyretic activity test, the crude extract was most effective at a dose of 500 mg/kg. Overall, the findings indicate the presence of potential therapeutic bioactive compounds in the plant.